CBX7 reduces the emergence of breast adenocarcinoma by inhibiting the Wnt/β-catenin pathway via upregulation of the Wnt antagonist DKK-1 expression (Kim et al., 2015). The gene discussed is DKK1; the disease is breast adenocarcinoma.